Heart failure in clinical practice
Author(s)
Bibliographic Information
Heart failure in clinical practice
Dunitz, 1996
Available at 2 libraries
  Aomori
  Iwate
  Miyagi
  Akita
  Yamagata
  Fukushima
  Ibaraki
  Tochigi
  Gunma
  Saitama
  Chiba
  Tokyo
  Kanagawa
  Niigata
  Toyama
  Ishikawa
  Fukui
  Yamanashi
  Nagano
  Gifu
  Shizuoka
  Aichi
  Mie
  Shiga
  Kyoto
  Osaka
  Hyogo
  Nara
  Wakayama
  Tottori
  Shimane
  Okayama
  Hiroshima
  Yamaguchi
  Tokushima
  Kagawa
  Ehime
  Kochi
  Fukuoka
  Saga
  Nagasaki
  Kumamoto
  Oita
  Miyazaki
  Kagoshima
  Okinawa
  Korea
  China
  Thailand
  United Kingdom
  Germany
  Switzerland
  France
  Belgium
  Netherlands
  Sweden
  Norway
  United States of America
Description and Table of Contents
Description
This work presents the views of a team of international cardiologists on the subject of developments in the diverse area of heart failure. The contributors cover current issues and treatments including beta blockers, and the economic effects of the use of ACE inhibitors.
Table of Contents
- Historical introduction
- what do we mean by heart failure
- how common and how much of a problem is heart failure
- the economic effects of ACE inhibitors
- heart failure in the elderly
- what are we trying to achieve when we treat heart failure
- HIV infection and the heart
- ACE genotype, myocardial infarction and heart failure
- the effects of chronic heart failure on pulmonary function
- the ABC of natriuretic peptides - pathophysiology, diagnostic and therapeutic potential
- endothelin in the pathophysiology of chonic heart failure
- aldosterone in chronic heart failure
- which exercise test, if any
- arrythmias and sudden death in heart failure
- current perspective on beta-blockers in heart failure
- what lessons should we learn from the negative trials
- digitalis in the 21st century
- inotropic agents
- angiotensin II receptor antagonists for heart failure
- the ongoing trials and unanswered questions.
by "Nielsen BookData"